Pediatric HIV Infection Treatment Market, Global Outlook and Forecast 2022-2028
Over 1.8 million children across the globe are affected from HIV, while only half of these have access to the antiretroviral therapy (ART), according to the UNICEF
This report contains market size and forecasts of Pediatric HIV Infection Treatment in Global, including the following market information:
Global Pediatric HIV Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pediatric HIV Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Not Symptomatic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pediatric HIV Infection Treatment include GSK, F.Hoffmann-La Roche, Johnson & Johnson Services, ViiV Healthcare, Apotex and Camber Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pediatric HIV Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric HIV Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pediatric HIV Infection Treatment Market Segment Percentages, by Type, 2021 (%)
Global Pediatric HIV Infection Treatment Market Segment Percentages, by Application, 2021 (%)
Global Pediatric HIV Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Pediatric HIV Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pediatric HIV Infection Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Pediatric HIV Infection Treatment in Global, including the following market information:
Global Pediatric HIV Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pediatric HIV Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Not Symptomatic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pediatric HIV Infection Treatment include GSK, F.Hoffmann-La Roche, Johnson & Johnson Services, ViiV Healthcare, Apotex and Camber Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pediatric HIV Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric HIV Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pediatric HIV Infection Treatment Market Segment Percentages, by Type, 2021 (%)
- Not Symptomatic
- Mildly Symptomatic
- Moderately Symptomatic
- Severely Symptomatic
Global Pediatric HIV Infection Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drugstore
- Others
Global Pediatric HIV Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Pediatric HIV Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pediatric HIV Infection Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GSK
- F.Hoffmann-La Roche
- Johnson & Johnson Services
- ViiV Healthcare
- Apotex
- Camber Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Pediatric HIV Infection Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatric HIV Infection Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PEDIATRIC HIV INFECTION TREATMENT OVERALL MARKET SIZE
2.1 Global Pediatric HIV Infection Treatment Market Size: 2021 VS 2028
2.2 Global Pediatric HIV Infection Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Pediatric HIV Infection Treatment Players in Global Market
3.2 Top Global Pediatric HIV Infection Treatment Companies Ranked by Revenue
3.3 Global Pediatric HIV Infection Treatment Revenue by Companies
3.4 Top 3 and Top 5 Pediatric HIV Infection Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pediatric HIV Infection Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pediatric HIV Infection Treatment Players in Global Market
3.6.1 List of Global Tier 1 Pediatric HIV Infection Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Pediatric HIV Infection Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Pediatric HIV Infection Treatment Market Size Markets, 2021 & 2028
4.1.2 Not Symptomatic
4.1.3 Mildly Symptomatic
4.1.4 Moderately Symptomatic
4.1.5 Severely Symptomatic
4.2 By Type - Global Pediatric HIV Infection Treatment Revenue & Forecasts
4.2.1 By Type - Global Pediatric HIV Infection Treatment Revenue, 2017-2022
4.2.2 By Type - Global Pediatric HIV Infection Treatment Revenue, 2023-2028
4.2.3 By Type - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pediatric HIV Infection Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Drugstore
5.1.6 Others
5.2 By Application - Global Pediatric HIV Infection Treatment Revenue & Forecasts
5.2.1 By Application - Global Pediatric HIV Infection Treatment Revenue, 2017-2022
5.2.2 By Application - Global Pediatric HIV Infection Treatment Revenue, 2023-2028
5.2.3 By Application - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pediatric HIV Infection Treatment Market Size, 2021 & 2028
6.2 By Region - Global Pediatric HIV Infection Treatment Revenue & Forecasts
6.2.1 By Region - Global Pediatric HIV Infection Treatment Revenue, 2017-2022
6.2.2 By Region - Global Pediatric HIV Infection Treatment Revenue, 2023-2028
6.2.3 By Region - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pediatric HIV Infection Treatment Revenue, 2017-2028
6.3.2 US Pediatric HIV Infection Treatment Market Size, 2017-2028
6.3.3 Canada Pediatric HIV Infection Treatment Market Size, 2017-2028
6.3.4 Mexico Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pediatric HIV Infection Treatment Revenue, 2017-2028
6.4.2 Germany Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.3 France Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.4 U.K. Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.5 Italy Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.6 Russia Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.8 Benelux Pediatric HIV Infection Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pediatric HIV Infection Treatment Revenue, 2017-2028
6.5.2 China Pediatric HIV Infection Treatment Market Size, 2017-2028
6.5.3 Japan Pediatric HIV Infection Treatment Market Size, 2017-2028
6.5.4 South Korea Pediatric HIV Infection Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Pediatric HIV Infection Treatment Market Size, 2017-2028
6.5.6 India Pediatric HIV Infection Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pediatric HIV Infection Treatment Revenue, 2017-2028
6.6.2 Brazil Pediatric HIV Infection Treatment Market Size, 2017-2028
6.6.3 Argentina Pediatric HIV Infection Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pediatric HIV Infection Treatment Revenue, 2017-2028
6.7.2 Turkey Pediatric HIV Infection Treatment Market Size, 2017-2028
6.7.3 Israel Pediatric HIV Infection Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Pediatric HIV Infection Treatment Market Size, 2017-2028
6.7.5 UAE Pediatric HIV Infection Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Pediatric HIV Infection Treatment Major Product Offerings
7.1.4 GSK Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.1.5 GSK Key News
7.2 F.Hoffmann-La Roche
7.2.1 F.Hoffmann-La Roche Corporate Summary
7.2.2 F.Hoffmann-La Roche Business Overview
7.2.3 F.Hoffmann-La Roche Pediatric HIV Infection Treatment Major Product Offerings
7.2.4 F.Hoffmann-La Roche Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.2.5 F.Hoffmann-La Roche Key News
7.3 Johnson & Johnson Services
7.3.1 Johnson & Johnson Services Corporate Summary
7.3.2 Johnson & Johnson Services Business Overview
7.3.3 Johnson & Johnson Services Pediatric HIV Infection Treatment Major Product Offerings
7.3.4 Johnson & Johnson Services Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.3.5 Johnson & Johnson Services Key News
7.4 ViiV Healthcare
7.4.1 ViiV Healthcare Corporate Summary
7.4.2 ViiV Healthcare Business Overview
7.4.3 ViiV Healthcare Pediatric HIV Infection Treatment Major Product Offerings
7.4.4 ViiV Healthcare Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.4.5 ViiV Healthcare Key News
7.5 Apotex
7.5.1 Apotex Corporate Summary
7.5.2 Apotex Business Overview
7.5.3 Apotex Pediatric HIV Infection Treatment Major Product Offerings
7.5.4 Apotex Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.5.5 Apotex Key News
7.6 Camber Pharmaceuticals
7.6.1 Camber Pharmaceuticals Corporate Summary
7.6.2 Camber Pharmaceuticals Business Overview
7.6.3 Camber Pharmaceuticals Pediatric HIV Infection Treatment Major Product Offerings
7.6.4 Camber Pharmaceuticals Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.6.5 Camber Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Pediatric HIV Infection Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatric HIV Infection Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PEDIATRIC HIV INFECTION TREATMENT OVERALL MARKET SIZE
2.1 Global Pediatric HIV Infection Treatment Market Size: 2021 VS 2028
2.2 Global Pediatric HIV Infection Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Pediatric HIV Infection Treatment Players in Global Market
3.2 Top Global Pediatric HIV Infection Treatment Companies Ranked by Revenue
3.3 Global Pediatric HIV Infection Treatment Revenue by Companies
3.4 Top 3 and Top 5 Pediatric HIV Infection Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pediatric HIV Infection Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pediatric HIV Infection Treatment Players in Global Market
3.6.1 List of Global Tier 1 Pediatric HIV Infection Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Pediatric HIV Infection Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Pediatric HIV Infection Treatment Market Size Markets, 2021 & 2028
4.1.2 Not Symptomatic
4.1.3 Mildly Symptomatic
4.1.4 Moderately Symptomatic
4.1.5 Severely Symptomatic
4.2 By Type - Global Pediatric HIV Infection Treatment Revenue & Forecasts
4.2.1 By Type - Global Pediatric HIV Infection Treatment Revenue, 2017-2022
4.2.2 By Type - Global Pediatric HIV Infection Treatment Revenue, 2023-2028
4.2.3 By Type - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pediatric HIV Infection Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Drugstore
5.1.6 Others
5.2 By Application - Global Pediatric HIV Infection Treatment Revenue & Forecasts
5.2.1 By Application - Global Pediatric HIV Infection Treatment Revenue, 2017-2022
5.2.2 By Application - Global Pediatric HIV Infection Treatment Revenue, 2023-2028
5.2.3 By Application - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pediatric HIV Infection Treatment Market Size, 2021 & 2028
6.2 By Region - Global Pediatric HIV Infection Treatment Revenue & Forecasts
6.2.1 By Region - Global Pediatric HIV Infection Treatment Revenue, 2017-2022
6.2.2 By Region - Global Pediatric HIV Infection Treatment Revenue, 2023-2028
6.2.3 By Region - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pediatric HIV Infection Treatment Revenue, 2017-2028
6.3.2 US Pediatric HIV Infection Treatment Market Size, 2017-2028
6.3.3 Canada Pediatric HIV Infection Treatment Market Size, 2017-2028
6.3.4 Mexico Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pediatric HIV Infection Treatment Revenue, 2017-2028
6.4.2 Germany Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.3 France Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.4 U.K. Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.5 Italy Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.6 Russia Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Pediatric HIV Infection Treatment Market Size, 2017-2028
6.4.8 Benelux Pediatric HIV Infection Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pediatric HIV Infection Treatment Revenue, 2017-2028
6.5.2 China Pediatric HIV Infection Treatment Market Size, 2017-2028
6.5.3 Japan Pediatric HIV Infection Treatment Market Size, 2017-2028
6.5.4 South Korea Pediatric HIV Infection Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Pediatric HIV Infection Treatment Market Size, 2017-2028
6.5.6 India Pediatric HIV Infection Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pediatric HIV Infection Treatment Revenue, 2017-2028
6.6.2 Brazil Pediatric HIV Infection Treatment Market Size, 2017-2028
6.6.3 Argentina Pediatric HIV Infection Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pediatric HIV Infection Treatment Revenue, 2017-2028
6.7.2 Turkey Pediatric HIV Infection Treatment Market Size, 2017-2028
6.7.3 Israel Pediatric HIV Infection Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Pediatric HIV Infection Treatment Market Size, 2017-2028
6.7.5 UAE Pediatric HIV Infection Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Pediatric HIV Infection Treatment Major Product Offerings
7.1.4 GSK Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.1.5 GSK Key News
7.2 F.Hoffmann-La Roche
7.2.1 F.Hoffmann-La Roche Corporate Summary
7.2.2 F.Hoffmann-La Roche Business Overview
7.2.3 F.Hoffmann-La Roche Pediatric HIV Infection Treatment Major Product Offerings
7.2.4 F.Hoffmann-La Roche Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.2.5 F.Hoffmann-La Roche Key News
7.3 Johnson & Johnson Services
7.3.1 Johnson & Johnson Services Corporate Summary
7.3.2 Johnson & Johnson Services Business Overview
7.3.3 Johnson & Johnson Services Pediatric HIV Infection Treatment Major Product Offerings
7.3.4 Johnson & Johnson Services Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.3.5 Johnson & Johnson Services Key News
7.4 ViiV Healthcare
7.4.1 ViiV Healthcare Corporate Summary
7.4.2 ViiV Healthcare Business Overview
7.4.3 ViiV Healthcare Pediatric HIV Infection Treatment Major Product Offerings
7.4.4 ViiV Healthcare Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.4.5 ViiV Healthcare Key News
7.5 Apotex
7.5.1 Apotex Corporate Summary
7.5.2 Apotex Business Overview
7.5.3 Apotex Pediatric HIV Infection Treatment Major Product Offerings
7.5.4 Apotex Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.5.5 Apotex Key News
7.6 Camber Pharmaceuticals
7.6.1 Camber Pharmaceuticals Corporate Summary
7.6.2 Camber Pharmaceuticals Business Overview
7.6.3 Camber Pharmaceuticals Pediatric HIV Infection Treatment Major Product Offerings
7.6.4 Camber Pharmaceuticals Pediatric HIV Infection Treatment Revenue in Global Market (2017-2022)
7.6.5 Camber Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Pediatric HIV Infection Treatment Market Opportunities & Trends in Global Market
Table 2. Pediatric HIV Infection Treatment Market Drivers in Global Market
Table 3. Pediatric HIV Infection Treatment Market Restraints in Global Market
Table 4. Key Players of Pediatric HIV Infection Treatment in Global Market
Table 5. Top Pediatric HIV Infection Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pediatric HIV Infection Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pediatric HIV Infection Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pediatric HIV Infection Treatment Product Type
Table 9. List of Global Tier 1 Pediatric HIV Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric HIV Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pediatric HIV Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pediatric HIV Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pediatric HIV Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pediatric HIV Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pediatric HIV Infection Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pediatric HIV Infection Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK Pediatric HIV Infection Treatment Product Offerings
Table 32. GSK Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 33. F.Hoffmann-La Roche Corporate Summary
Table 34. F.Hoffmann-La Roche Pediatric HIV Infection Treatment Product Offerings
Table 35. F.Hoffmann-La Roche Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Services Corporate Summary
Table 37. Johnson & Johnson Services Pediatric HIV Infection Treatment Product Offerings
Table 38. Johnson & Johnson Services Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 39. ViiV Healthcare Corporate Summary
Table 40. ViiV Healthcare Pediatric HIV Infection Treatment Product Offerings
Table 41. ViiV Healthcare Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Apotex Corporate Summary
Table 43. Apotex Pediatric HIV Infection Treatment Product Offerings
Table 44. Apotex Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Camber Pharmaceuticals Corporate Summary
Table 46. Camber Pharmaceuticals Pediatric HIV Infection Treatment Product Offerings
Table 47. Camber Pharmaceuticals Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 1. Pediatric HIV Infection Treatment Market Opportunities & Trends in Global Market
Table 2. Pediatric HIV Infection Treatment Market Drivers in Global Market
Table 3. Pediatric HIV Infection Treatment Market Restraints in Global Market
Table 4. Key Players of Pediatric HIV Infection Treatment in Global Market
Table 5. Top Pediatric HIV Infection Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pediatric HIV Infection Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pediatric HIV Infection Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pediatric HIV Infection Treatment Product Type
Table 9. List of Global Tier 1 Pediatric HIV Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric HIV Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pediatric HIV Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pediatric HIV Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pediatric HIV Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pediatric HIV Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pediatric HIV Infection Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pediatric HIV Infection Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK Pediatric HIV Infection Treatment Product Offerings
Table 32. GSK Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 33. F.Hoffmann-La Roche Corporate Summary
Table 34. F.Hoffmann-La Roche Pediatric HIV Infection Treatment Product Offerings
Table 35. F.Hoffmann-La Roche Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Services Corporate Summary
Table 37. Johnson & Johnson Services Pediatric HIV Infection Treatment Product Offerings
Table 38. Johnson & Johnson Services Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 39. ViiV Healthcare Corporate Summary
Table 40. ViiV Healthcare Pediatric HIV Infection Treatment Product Offerings
Table 41. ViiV Healthcare Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Apotex Corporate Summary
Table 43. Apotex Pediatric HIV Infection Treatment Product Offerings
Table 44. Apotex Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Camber Pharmaceuticals Corporate Summary
Table 46. Camber Pharmaceuticals Pediatric HIV Infection Treatment Product Offerings
Table 47. Camber Pharmaceuticals Pediatric HIV Infection Treatment Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Pediatric HIV Infection Treatment Segment by Type in 2021
Figure 2. Pediatric HIV Infection Treatment Segment by Application in 2021
Figure 3. Global Pediatric HIV Infection Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pediatric HIV Infection Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pediatric HIV Infection Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pediatric HIV Infection Treatment Revenue in 2021
Figure 8. By Type - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 12. US Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 24. China Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. GSK Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F.Hoffmann-La Roche Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Services Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ViiV Healthcare Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Apotex Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Camber Pharmaceuticals Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Pediatric HIV Infection Treatment Segment by Type in 2021
Figure 2. Pediatric HIV Infection Treatment Segment by Application in 2021
Figure 3. Global Pediatric HIV Infection Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pediatric HIV Infection Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pediatric HIV Infection Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pediatric HIV Infection Treatment Revenue in 2021
Figure 8. By Type - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 12. US Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 24. China Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pediatric HIV Infection Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pediatric HIV Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. GSK Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F.Hoffmann-La Roche Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Services Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ViiV Healthcare Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Apotex Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Camber Pharmaceuticals Pediatric HIV Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
